We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

290 hedge funds and large institutions have $2.91B invested in Amedisys in 2024 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 105 increasing their positions, 82 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 82

13% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 48

1.87% more ownership

Funds ownership: 96.06% → 97.94% (+1.9%)

2% more funds holding

Funds holding: 285 → 290 (+5)

4% less capital invested

Capital invested by funds: $3.04B → $2.91B (-$124M)

23% less funds holding in top 10

Funds holding in top 10: 13 → 10 (-3)

80% less call options, than puts

Call options by funds: $72M | Put options by funds: $360M

Holders
290
Holders Change
+5
Holders Change %
+1.75%
% of All Funds
3.82%
Holding in Top 10
10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-23.08%
% of All Funds
0.13%
New
54
Increased
105
Reduced
82
Closed
48
Calls
$72M
Puts
$360M
Net Calls
-$288M
Net Calls Change
-$206M

Top Buyers

1
TAL
TIG Advisors LLC
New York
+$65.2M
2
DKCM
Davidson Kempner Capital Management
New York
+$64M
3
Pacer Advisors
Pacer Advisors
Pennsylvania
+$50.8M
4
UOC
UBS O'Connor
Illinois
+$49.1M
5
Norges Bank
Norges Bank
Norway
+$48.3M

Top Sellers

1
WCMNY
Westchester Capital Management (New York)
New York
-$85.3M
2
FCM
Farallon Capital Management
California
-$64.3M
3
KLCMU
Kite Lake Capital Management (UK)
United Kingdom
-$52M
4
SGCM
Sand Grove Capital Management
United Kingdom
-$32.8M
5
Amundi
Amundi
France
-$27.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allspring Global Investments
326
Allspring Global Investments
North Carolina
– -$14.7K -152 Closed
WSFS
327
Wilmington Savings Fund Society
Delaware
– -$12.4K -128 Closed
SPIA
328
Steward Partners Investment Advisory
New York
– -$11K -114 Closed
FDCDDQ
329
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$8.2K -85 Closed
SSG
330
Summit Securities Group
New York
– -$5.97K -65 Closed
DIP
331
DT Investment Partners
Pennsylvania
– -$2.32K -24 Closed
CPA
332
Capital Performance Advisors
California
– -$1.74K -18 Closed
Fuller & Thaler Asset Management
333
Fuller & Thaler Asset Management
California
– -$1.54K -16 Closed
PWMG
334
Private Wealth Management Group
New Jersey
– -$1.16K -12 Closed
CPG
335
Cornerstone Planning Group
New Jersey
– -$477 -5 Closed
ATS
336
Ashton Thomas Securities
New York
– -$193 -2 Closed
CA
337
Claris Advisors
Missouri
– -$193 -2 Closed
CFGS
338
Concourse Financial Group Securities
Alabama
– -$92 -1 Closed
10 11 12 13
14

AMED Hedge Fund Activity: Q4 2024 in Review

290 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2024, worth a combined $2.91B — down 4.1% from $3.04B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new AMED positions and 48 closed out — a net gain of 6 holders — while 105 added to existing stakes and 82 trimmed.

The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $65.2M. The largest seller was Westchester Capital Management (New York), cutting an estimated $85.3M.

  • 290 institutional investors held Amedisys (AMED) as of Q4 2024, up from 285 in Q3 2024.
  • Funds reported $2.91B of Amedisys stock for Q4 2024, down 4.1% quarter-over-quarter.
  • 54 funds opened new Amedisys positions in Q4 2024 and 48 closed out, a net change of +6 holders.
  • The largest Amedisys buyer in Q4 2024 was TIG Advisors LLC, an estimated $65.2M added.
  • The largest Amedisys seller in Q4 2024 was Westchester Capital Management (New York), an estimated $85.3M sold.

Based on aggregated 13F filings for Q4 2024.